194 related articles for article (PubMed ID: 15899746)
1. Propofol: an immunomodulating agent.
Marik PE
Pharmacotherapy; 2005 May; 25(5 Pt 2):28S-33S. PubMed ID: 15899746
[TBL] [Abstract][Full Text] [Related]
2. Free radical and drug oxidation products in an intensive care unit sedative: propofol with sulfite.
Baker MT; Gregerson MS; Martin SM; Buettner GR
Crit Care Med; 2003 Mar; 31(3):787-92. PubMed ID: 12626985
[TBL] [Abstract][Full Text] [Related]
3. Sulfite supported lipid peroxidation in propofol emulsions.
Baker MT; Dehring DJ; Gregerson MS
Anesthesiology; 2002 Nov; 97(5):1162-7. PubMed ID: 12411802
[TBL] [Abstract][Full Text] [Related]
4. Effects of propofol containing EDTA on mineral metabolism in medical ICU patients with pulmonary dysfunction.
Abraham E; Papadakos PJ; Tharratt RS; Hall JB; Williams GJ
Intensive Care Med; 2000; 26 Suppl 4():S422-32. PubMed ID: 11310905
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of propofol with EDTA when used for sedation of surgical intensive care unit patients.
Herr DL; Kelly K; Hall JB; Ulatowski J; Fulda GJ; Cason B; Hickey R; Nejman AM; Zaloga GP; Teres D
Intensive Care Med; 2000; 26 Suppl 4():S452-62. PubMed ID: 11310908
[TBL] [Abstract][Full Text] [Related]
6. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.
Kotani Y; Shimazawa M; Yoshimura S; Iwama T; Hara H
CNS Neurosci Ther; 2008; 14(2):95-106. PubMed ID: 18482023
[TBL] [Abstract][Full Text] [Related]
7. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients.
Higgins TL; Murray M; Kett DH; Fulda G; Kramer KM; Gelmont D; Dedhia HV; Levy H; Teres D; Zaloga GP; Ko H; Thompson KA
Intensive Care Med; 2000; 26 Suppl 4():S413-21. PubMed ID: 11310904
[TBL] [Abstract][Full Text] [Related]
8. Propofol: therapeutic indications and side-effects.
Marik PE
Curr Pharm Des; 2004; 10(29):3639-49. PubMed ID: 15579060
[TBL] [Abstract][Full Text] [Related]
9. Cation metabolism during propofol sedation with and without EDTA in patients with impaired renal function.
Barr J; Zaloga GP; Haupt MT; Weinmann M; Murray MJ; Bandi V; Teres D
Intensive Care Med; 2000; 26 Suppl 4():S433-42. PubMed ID: 11310906
[TBL] [Abstract][Full Text] [Related]
10. The safety and efficacy of propofol containing EDTA: a randomised clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients.
Zaloga GP; Teres D
Intensive Care Med; 2000; 26 Suppl 4():S398-9. PubMed ID: 11310901
[No Abstract] [Full Text] [Related]
11. 'Diprivan': a change of formulation.
Hart B
Eur J Anaesthesiol; 2000 Jan; 17(1):71-3. PubMed ID: 10798895
[No Abstract] [Full Text] [Related]
12. Effect of propofol with and without EDTA on haemodynamics and calcium and magnesium homeostasis during and after cardiac surgery.
Wahr J; Vender J; Gilbert HC; Spiess B; Horrow JC; Maddi R
Intensive Care Med; 2000; 26 Suppl 4():S443-51. PubMed ID: 11310907
[TBL] [Abstract][Full Text] [Related]
13. Comparative study on determination of antioxidant and membrane activities of propofol and its related compounds.
Tsuchiya H; Ueno T; Tanaka T; Matsuura N; Mizogami M
Eur J Pharm Sci; 2010 Jan; 39(1-3):97-102. PubMed ID: 19897032
[TBL] [Abstract][Full Text] [Related]
14. Propofol-containing sedatives increase levels of parathyroid hormone.
Zaloga GP; Youngs E; Teres D
Intensive Care Med; 2000; 26 Suppl 4():S405-12. PubMed ID: 11310903
[TBL] [Abstract][Full Text] [Related]
15. Antioxidative effects of propofol vs. ketamin in individuals undergoing surgery.
Khoshraftar E; Ranjbar A; Kharkhane B; Tavakol Heidary S; Gharebaghi Z; Zadkhosh N
Arch Iran Med; 2014 Jul; 17(7):486-9. PubMed ID: 24979561
[TBL] [Abstract][Full Text] [Related]
16. "Preservatives" in propofol.
Craig DB
Can J Anaesth; 1998 Sep; 45(9):913. PubMed ID: 9818119
[No Abstract] [Full Text] [Related]
17. Comparison of a lower-lipid propofol emulsion with the standard emulsion for sedation during monitored anesthesia care.
Song D; Hamza MA; White PF; Byerly SI; Jones SB; Macaluso AD
Anesthesiology; 2004 May; 100(5):1072-5. PubMed ID: 15114202
[TBL] [Abstract][Full Text] [Related]
18. [Propofol up2date. Part 1: history and pharmacological characteristics].
Bushuven S; Heise D
Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jun; 48(6):378-85. PubMed ID: 23828078
[TBL] [Abstract][Full Text] [Related]
19. Sulfite-induced propofol oxidation: a cause for radical concern.
Zaloga GP; Marik P
Crit Care Med; 2003 Mar; 31(3):981-3. PubMed ID: 12627021
[No Abstract] [Full Text] [Related]
20. [Drugs for intravenous induction of anesthesia: propofol].
Bolkenius D; Dumps C; Halbeck E
Anaesthesist; 2018 Feb; 67(2):147-162. PubMed ID: 29335823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
